Evaluation of three methods for in vitro detection of antifungal susceptibility of Candida species

被引:0
|
作者
Maldonado, Ivana [1 ]
Fernandez Canigia, Liliana [1 ]
Vivot, Walter
Domecq, Patricia [1 ]
Davel, Graciela [2 ]
Cordoba, Susana [2 ]
机构
[1] Hosp Aleman, Secc Microbiol, Cent Lab, RA-1118 Buenos Aires, DF, Argentina
[2] INEI ANLIS Dr Carlos G Malbran, Dept Micol, Buenos Aires, DF, Argentina
来源
REVISTA ARGENTINA DE MICROBIOLOGIA | 2011年 / 43卷 / 02期
关键词
Candida; yeasts; antifungal susceptibility; BLOOD-STREAM INFECTIONS; ANTIMICROBIAL SURVEILLANCE PROGRAM; DISK DIFFUSION; BROTH MICRODILUTION; UNITED-STATES; FLUCONAZOLE; SPP; EPIDEMIOLOGY; ITRACONAZOLE; MORTALITY;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Evaluation of three methods for in vitro detection of antifungal susceptibility of Candida species. Reference methods E.Def 7.1 and M27-A3 detect in vitro resistance; however, they are expensive and very laborious. Thus, their actual use in hospital laboratories is limited. There are commercial techniques available, having easier accessibility and development, which would yield results comparable to those of the reference methods. The objectives of this study were: a) to compare the results of minimal inhibitory concentration of 82 Candida spp. clinic isolates according to reference method E.Def 7.1 and ATB (R) Fungus 3; b) to compare the results of fluconazole susceptibility testing by disk diffusion in agar with Neo-Sensitabs (TM) tablets and Malbran disks with those of the reference methods. Minimal inhibitory concentration for amphotericin B, 5-flucytosine, fluconazole and itraconazole was performed according to the E.Def 7.1 and the ATB Fungus 3 methods and diffusion was carried out with fluconazole disks and tablets. General concordance between the reference method and ATB Fungus 3 was 90.2 % and 96.3 and 92.7% for diffusion with disks and tablets. The ATB Fungus 3 method was effective to determine susceptibility against amphotericin B and 5-flucytosine; however, discrepancies were observed with azole drugs. Disk diffusion methods are useful to determine susceptibility to fluconazole; however, 3 very major, 1 major and 2 minor errors were observed with the tablets, whereas only 3 minor errors were observed with the disks.
引用
收藏
页码:120 / 126
页数:7
相关论文
共 50 条
  • [21] In vitro antifungal susceptibility of Candida species isolated from oropharyngeal lesions of patients with cancer to some antifungal agents
    Shokohi, Tahereh
    Bandalizadeh, Zainab
    Hedayati, Mohmmad Taghi
    Mayahi, Sabah
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2011, 4 : S19 - S26
  • [22] Methods for in vitro antifungal susceptibility testing
    Dannaoui, Eric
    THERAPIE, 2006, 61 (03): : 201 - 207
  • [23] In vitro susceptibility of oral Candida to seven antifungal agents
    Kuriyama, T
    Williams, DW
    Bagg, J
    Coulter, WA
    Ready, D
    Lewis, MAO
    ORAL MICROBIOLOGY AND IMMUNOLOGY, 2005, 20 (06): : 349 - 353
  • [24] Candida Distribution in Onychomycosis and in vitro Susceptibility to Antifungal Agents
    Paskevicius, Algimantas
    Svediene, Jurgita
    Kiveryte, Silvija
    Bridziuviene, Danguole
    Vaitonis, Gintautas
    Jablonskiene, Valerija
    ACTA DERMATOVENEROLOGICA CROATICA, 2020, 28 (04) : 204 - 209
  • [25] In vitro susceptibility of Candida species to lactoferrin
    Xu, YY
    Samaranayake, YH
    Samaranayake, LP
    Nikawa, H
    MEDICAL MYCOLOGY, 1999, 37 (01) : 35 - 41
  • [26] In vitro susceptibility of Candida species to echinocandins
    Garcia-Agudo, L.
    Aznar-Marin, P.
    Canadas-Martos, J.
    Garcia-Martos, P.
    Marin-Casanova, P.
    Rodriguez-Iglesias, M.
    MYCOSES, 2011, 54 : 168 - 168
  • [27] Candidemia in ICU patients: Candida species and antifungal susceptibility
    Routsi, C
    Platsouka, E
    Charalambidis, C
    Belessiotou, E
    Perivolioti, E
    Paniara, O
    Roussos, C
    INTENSIVE CARE MEDICINE, 2002, 28 : S120 - S120
  • [28] Antifungal susceptibility testing of Candida species by flow cytometry
    Lee, W
    Kwak, Y
    JOURNAL OF KOREAN MEDICAL SCIENCE, 1999, 14 (01) : 21 - 26
  • [29] Identification of Candida species and investigating antifungal susceptibility in Turkey
    Aydin, E.
    Karakas, A.
    Savasci, U.
    Akpak, Y. K.
    Caymaz, S. O.
    Aydin, S.
    Metin, D. Y.
    Ozgenc, O.
    Avci, M.
    Gul, H. C.
    Coskun, O.
    Coskuner, S. A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 289 - 289
  • [30] Update on clinical antifungal susceptibility testing for Candida species
    Lewis, RE
    Klepser, ME
    Pfaller, MA
    PHARMACOTHERAPY, 1998, 18 (03): : 509 - 515